TrivarX (ASX:TRI) Other Current Payables: A$0.00 Mil (As of Dec. 2025)


What is TrivarX Other Current Payables?

TrivarX ASX:TRI +5.56% Other Current Payables is A$0.00 Mil as of Dec. 2025. The stock has 2 warning signs investors should review.

TrivarX's Other Current Payables for the quarter that ended in Dec. 2025 was A$0.00 Mil.

TrivarX Other Current Payables Related Terms

TrivarX Other Current Payables Historical Data

* Premium members only.

The historical data trend for TrivarX's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TrivarX Other Current Payables Chart

TrivarX Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

TrivarX Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

TrivarX Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of A$0.00 Mil mean?
TrivarX (ASX:TRI) has a Other Current Payables of A$0.00 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on TrivarX and its competitors.
Is TrivarX's Other Current Payables too high?
TrivarX's current Other Current Payables is A$0.00 Mil.
How does TrivarX's Other Current Payables compare to VEEV and BTSG?
TrivarX's Other Current Payables of A$0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Healthcare Providers & Services company?
A good Other Current Payables depends on the Healthcare Providers & Services industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on TrivarX and its competitors. TrivarX's current Other Current Payables is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TrivarX stock overvalued right now?
TrivarX (ASX:TRI) has a current Other Current Payables of A$0.00 Mil. The current Other Current Payables is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For TrivarX (ASX:TRI), the current Other Current Payables is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TrivarX Business Description

Other Exchanges MDBIF:USA
Address 647 Beaufort Street, Mount Lawley, WA, AUS, 6050
TrivarX Ltd is a health technology company developing AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions. Trivarx's clinical research has enabled the development of cutting-edge proprietary algorithms for spectral analyses of sleep architecture and heart rate variability. The Company has one operating segment, being the research, development and commercialisation of its software asaService product, and two geographical locations, being Australia and the United States.